X0508 4 2024-07-15 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001918845 Doyle Mittie C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 0 1 0 0 Chief Medical Officer 0 Stock Option (Right to Buy) 12.65 2024-07-15 4 A 0 234000 0 A 2034-07-15 Common Stock 234000 234000 D Twenty-five percent (25%) of the Option Shares vest on July 15, 2025 and the remainder of the Option Shares will vest in equal monthly installments over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date. /s/ Donald R. Reynolds, by Power of Attorney 2024-07-16